Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth

被引:282
作者
Sellers, WR
Novitch, BG
Miyake, S
Heith, A
Otterson, GA
Kaye, FJ
Lassar, AB
Kaelin, WG [1 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[3] NCI, USN, Med Oncol Branch, Div Clin Sci, Bethesda, MD 20889 USA
关键词
retinoblastoma; transcription; E2F; tumorigenesis;
D O I
10.1101/gad.12.1.95
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The retinoblastoma tumor suppressor protein (pRB) can inhibit cell cycle progression and promote differentiation. pRB interacts with a variety of transcription factors, including members of the E2F and C-EBP protein families and MyoD, and can either repress or activate transcription depending on the promoter under study. These biological and biochemical activities of pRB have been mapped previously to a core domain, referred to as the pRB pocket. Using a panel of synthetic pRB pocket mutants, we found that the acute induction of a G(1)/S block by pRB is linked to its ability to both bind to E2F and to repress transcription. In contrast, these functions were not required for pRB to promote differentiation, which correlated with its ability to activate transcription in concert with fate-determining proteins such as MyoD. All tumor-derived PRE mutants tested to date failed to bind to E2F and did not repress transcription. Despite an inability to bind to E2F, pRB mutants associated with a low risk of retinoblastoma, unlike high-risk mutants, retained the ability to activate transcription and promote differentiation. Thus, the pRB pocket participates in dual tumor suppressor functions, one linked to cell cycle progression and the other to differentiation control, and these functions can be genetically and mechanistically dissociated.
引用
收藏
页码:95 / 106
页数:12
相关论文
共 59 条
  • [1] TRANSCRIPTIONAL CONTROL BY E2F
    ADAMS, PD
    KAELIN, WG
    [J]. SEMINARS IN CANCER BIOLOGY, 1995, 6 (02) : 99 - 108
  • [2] THE RETINOBLASTOMA SUSCEPTIBILITY GENE-PRODUCT REPRESSES TRANSCRIPTION WHEN DIRECTLY BOUND TO THE PROMOTER
    ADNANE, J
    SHAO, ZH
    ROBBINS, PD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (15) : 8837 - 8843
  • [3] PPAR gamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A
    Altiok, S
    Xu, M
    Spiegelman, BM
    [J]. GENES & DEVELOPMENT, 1997, 11 (15) : 1987 - 1998
  • [4] [Anonymous], 1988, Antibodies: A Laboratory Manual
  • [5] Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells
    Asahina, I
    Sampath, TK
    Hauschka, PV
    [J]. EXPERIMENTAL CELL RESEARCH, 1996, 222 (01) : 38 - 47
  • [6] SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53
    BAKER, SJ
    MARKOWITZ, S
    FEARON, ER
    WILLSON, JKV
    VOGELSTEIN, B
    [J]. SCIENCE, 1990, 249 (4971) : 912 - 915
  • [7] Botz J, 1996, MOL CELL BIOL, V16, P3401
  • [8] BREMNER R, 1995, MOL CELL BIOL, V15, P3256
  • [9] INDEPENDENT BINDING OF THE RETINOBLASTOMA PROTEIN AND P107 TO THE TRANSCRIPTION FACTOR E2F
    CAO, L
    FAHA, B
    DEMBSKI, M
    TSAI, LH
    HARLOW, E
    DYSON, N
    [J]. NATURE, 1992, 355 (6356) : 176 - 179
  • [10] HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA
    CHEN, C
    OKAYAMA, H
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) : 2745 - 2752